The authors note that there are several overlapping risk factors for CVD and breast cancer, including obesity and smoking.
(CNN)Prostate cancer now kills more people in the United Kingdom than breast cancer, according to numbers released Friday byProstate Cancer UK.
It's essential for cancer patients and their clinicians to pay close attention to overall health-including heart function-before, during and after cancer treatments, she said. Dr. Susan Gilchrist, a cardiologist at MD Anderson Cancer Center who runs the only USA program for women's heart health after cancer, said she would treat hypertension, obesity, and other risk factors even more aggressively in a patient who had received doxorubicin, for instance.
It noted that breast cancer survivors who are 65 and older and were treated for their cancer are more likely to die of cardiovascular problems than breast cancer.
Experts credit the discrepancy to the sheer number of organizations raising funds, worldwide, and the massive public relations efforts to stamp out breast cancer.
Prostate cancer has overtaken breast cancer to become the third biggest cancer killer in the United Kingdom, new research shows. While much of the information is known to oncologists, the report could be a helpful reference tool for patients as well as primary care, emergency room and other doctors who treat breast cancer patients.
She said: "We need better tools to make these decisions more informed". In some cases, pre-existing heart conditions may guide the course of cancer care, or cancer therapy may adversely affect the heart and necessitate changes in treatment plans.
Cardiovascular disease is the leading cause of mortality in women, accounting for 1 in 3 deaths. Small studies also have shown that a drug called dexrazonxane can reduce the risk of heart damage in patients getting high doses of doxorubicin for advanced breast cancer, it added. Both can weaken the heart muscle.
"Then it becomes, 'What are the side effects?' " Mehta said. For instance, the chemotherapy drug doxorubicin can damage heart cells, but studies have found that when doxorubicin is administered slowly, rather than all at once, the risk of heart failure may be reduced.
"But while the rate of people dying from cancer overall is decreasing, the overall number of people developing and dying from cancer in the United Kingdom and worldwide is expected to rise".
Men who are black, overweight, over 50 or have a family history of prostate cancer are most at risk. 'Modern treatment is essential for fighting breast cancer and improving survival'.
I always refer to it as my little broken heart, she said. Some breast cancer treatment agents, such as anthracyclines, can result in abnormal heart rhythms, and can lead to life-threatening heart rhythms in others.